A new trading day began on Friday, with X4 Pharmaceuticals Inc (NASDAQ: XFOR) down -9.91% from the previous day of trading, before settling in for the closing price of $3.43. XFOR’s price has ranged from $1.35 to $26.83 over the past 52 weeks.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 47.41%. Meanwhile, its annual earnings per share averaged 57.41%. With a float of $14.50 million, this company’s outstanding shares have now reached $22.45 million.
X4 Pharmaceuticals Inc (XFOR) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of X4 Pharmaceuticals Inc is 35.41%, while institutional ownership is 23.43%. The most recent insider transaction that took place on May 16 ’25, was worth 2,561. In this transaction Chief Commercial Officer of this company bought 1,032 shares at a rate of $2.48, taking the stock ownership to the 25,337 shares. Before that another transaction happened on Nov 15 ’24, when Company’s Chief Commercial Officer bought 13,404 for $0.34, making the entire transaction worth $4,598. This insider now owns 129,173 shares in total.
X4 Pharmaceuticals Inc (XFOR) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -5.4 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.7 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 57.41% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 68.20% during the next five years compared to 47.41% growth over the previous five years of trading.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Trading Performance Indicators
Here are X4 Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.05. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -14.80, a number that is poised to hit -0.55 in the next quarter and is forecasted to reach -1.22 in one year’s time.
